KR890700599A - 아미노알킬 측쇄를 갖는 사이클릭 탄화수소 - Google Patents
아미노알킬 측쇄를 갖는 사이클릭 탄화수소Info
- Publication number
- KR890700599A KR890700599A KR1019880701683A KR880701683A KR890700599A KR 890700599 A KR890700599 A KR 890700599A KR 1019880701683 A KR1019880701683 A KR 1019880701683A KR 880701683 A KR880701683 A KR 880701683A KR 890700599 A KR890700599 A KR 890700599A
- Authority
- KR
- South Korea
- Prior art keywords
- hydrogen
- formula
- side chains
- cyclic hydrocarbon
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Toxicology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Lubricants (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3904287A | 1987-04-16 | 1987-04-16 | |
| US039,042 | 1987-04-16 | ||
| US6227687A | 1987-06-15 | 1987-06-15 | |
| US062,276 | 1987-06-15 | ||
| PCT/US1988/000978 WO1988008002A1 (en) | 1987-04-16 | 1988-04-01 | Cyclic hydrocarbons with an aminoalkyl sidechain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR890700599A true KR890700599A (ko) | 1989-04-26 |
| KR960002913B1 KR960002913B1 (ko) | 1996-02-28 |
Family
ID=26715768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019880701683A KR960002913B1 (ko) | 1987-04-16 | 1988-04-01 | 아미노알킬 측쇄를 갖는 사이클릭 탄화수소 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0356454B1 (ko) |
| JP (1) | JPH02502997A (ko) |
| KR (1) | KR960002913B1 (ko) |
| AT (1) | ATE77387T1 (ko) |
| AU (1) | AU1628288A (ko) |
| DE (1) | DE3872234T2 (ko) |
| DK (1) | DK697988A (ko) |
| WO (1) | WO1988008002A1 (ko) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
| US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
| US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
| US6995278B2 (en) | 2000-08-18 | 2006-02-07 | Entre Med, Inc. | Antiangiogenic agents |
| US7135581B2 (en) | 2000-08-18 | 2006-11-14 | Entremed, Inc. | Antiangiogenic agents |
| AU8838601A (en) * | 2000-11-27 | 2002-06-03 | Entremed Inc | Antiangiogenic agents |
| DE10135027A1 (de) * | 2001-07-18 | 2003-02-06 | Solvay Pharm Gmbh | Verwendung Trifluoracetylalkyl-substituierter Phenyl-, Phenol- und Benzoylderivate in der Behandlung und/oder Prophylaxe von Obestias und deren Begleit- und/oder Folgeerkrankungen |
| EP1581095A4 (en) * | 2002-06-27 | 2006-10-18 | Harkness Pharmaceuticals Inc | THERAPEUTIC METHODS FOR REDUCING FAT DEPOSIT AND TREATING THE DISEASES THEREOF |
| CA2558014A1 (en) | 2004-03-12 | 2005-09-29 | Entremed, Inc. | Antiangiogenic agents |
| CA2646065C (en) | 2006-03-20 | 2014-01-14 | Entremed, Inc. | Disease modifying anti-arthritic activity of 2-methoxyestradiol |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3107255A (en) * | 1962-08-03 | 1963-10-15 | Searle & Co | Nu-(dialkylaminoalkyl) androstanyl-17beta-amines, nu-alkyl derivatives thereof, and 2, 3-dehydro compounds corresponding |
| US4917826A (en) * | 1985-10-18 | 1990-04-17 | The Upjohn Company | Cyclic hydrocarbons with an aminoalkyl sidechain |
-
1988
- 1988-04-01 KR KR1019880701683A patent/KR960002913B1/ko active IP Right Grant
- 1988-04-01 AT AT88903641T patent/ATE77387T1/de active
- 1988-04-01 WO PCT/US1988/000978 patent/WO1988008002A1/en active IP Right Grant
- 1988-04-01 AU AU16282/88A patent/AU1628288A/en not_active Abandoned
- 1988-04-01 DE DE8888903641T patent/DE3872234T2/de not_active Expired - Fee Related
- 1988-04-01 JP JP63503552A patent/JPH02502997A/ja active Pending
- 1988-04-01 EP EP88903641A patent/EP0356454B1/en not_active Expired - Lifetime
- 1988-12-15 DK DK697988A patent/DK697988A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE77387T1 (de) | 1992-07-15 |
| EP0356454B1 (en) | 1992-06-17 |
| DE3872234T2 (de) | 1993-01-07 |
| JPH02502997A (ja) | 1990-09-20 |
| WO1988008002A1 (en) | 1988-10-20 |
| KR960002913B1 (ko) | 1996-02-28 |
| DK697988D0 (da) | 1988-12-15 |
| AU1628288A (en) | 1988-11-04 |
| EP0356454A1 (en) | 1990-03-07 |
| DE3872234D1 (de) | 1992-07-23 |
| DK697988A (da) | 1989-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1107956T1 (el) | Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον | |
| Brodde | Vascular dopamine receptors: demonstration and characterization by in vitro studies | |
| KR890700599A (ko) | 아미노알킬 측쇄를 갖는 사이클릭 탄화수소 | |
| MXPA04009784A (es) | Tiazolidin-4-carbonitrilos y analogos y su uso como inhibidores de dipeptidil-peptidas. | |
| KR960007545A (ko) | 합성 흥분성 아미노산 | |
| TR200101478T2 (tr) | Organik bileşikler. | |
| BR0213455A (pt) | Composto, seu uso, composição farmacêutica, método para o tratamento ou prevenção de uma doença para a qual um receptor adenosina está relacionado, e método para promover a defecação | |
| ATE115573T1 (de) | Neue stilbenderivate, ihre herstellung und verwendung für heilmittel. | |
| EA200601295A1 (ru) | Производные 1,3-диоксана и их аналоги, применимые для лечения i.a. ожирения и диабета | |
| PA8477001A1 (es) | Inhibidores no peptidilicos de la union a las celulas dependientes de la vla-4 utiles en el tratamiento de enfermedades inflamatorias autoinmunes y respiratorias | |
| NO20014925L (no) | Farmasöytiske forbindelser | |
| ES2036562T3 (es) | Un procedimiento para produccion de un derivado de pirrolidinamida. | |
| ATE25977T1 (de) | Furanonderivate, verfahren zu ihrer herstellung und ihre verwendung. | |
| FI73992B (fi) | Foerfarande foer framstaellning av 4-(3-trifluormetylfenyl-1,2,3,6-tetrahydropyridiner, vilka har anorektisk aktivitet. | |
| EA200500348A1 (ru) | N-арилпиперидинзамещенные бифенилкарбоксамиды в качестве ингибиторов секреции аполипопротеина b | |
| DE69102936D1 (de) | Bis(alkyl-substituierte-4-hydroxyphenylthio)alkan-Analoga als Inhibitoren der Kataraktentstehung. | |
| KR890011596A (ko) | 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도 | |
| FR2446838A1 (fr) | Derives peptidiques d'acides phosphoniques | |
| ATE180669T1 (de) | Verwendung von pregnanderivaten zur behandlung von tumoren | |
| ATE346040T1 (de) | Aryl-sulfonamide als serotonin-antagonisten für de behandlung von fettleibigkeit | |
| ATE88634T1 (de) | Arzneimittel zur behandlung von herzinsuffizienz. | |
| KR890700131A (ko) | 신규 화합물 | |
| KR850007069A (ko) | N-아실화 1-알킬아미노-1-데옥시-케토오스 유도체의 제조방법 | |
| ATE146078T1 (de) | Verwendung von xanthinderivaten zur behandlung von muskelschädigungen nach vollständiger unterbrechung der blutzirkulation | |
| DE3161640D1 (en) | Propanol amine, derivatives, process for their preparation and medicines containing these compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| G160 | Decision to publish patent application | ||
| E701 | Decision to grant or registration of patent right | ||
| NORF | Unpaid initial registration fee |